Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine as an additive to ropivacaine TAP block after gynecological surgery
ACTRN12614000587606Phase 3Completed
- Sponsor
- Royal Prince Alfred Hospital
- Start
- Jun 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of clonidine, ropivacaine and epinephrine in postoperative pain (4 arms), sponsored by Royal Prince Alfred Hospital. Primary endpoint: Plasma ropivacaine levels. Started Jun 2014; status: completed.
02
Drugs
clonidineropivacaineepinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12614000587606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000587606.